Care of patients with hepatitis C and HIV co-infection

被引:171
作者
Soriano, V
Puoti, M
Sulkowski, M
Mauss, S
Cacoub, P
Cargnel, A
Dieterich, D
Hatzakis, A
Rockstroh, J
机构
[1] Inst Salud Carlos III, Infect Dis Serv, Madrid, Spain
[2] Spedali Civil Brescia, Clin Malattie Infett & Trop, I-25125 Brescia, Italy
[3] Johns Hopkins Univ, Sch Med, Div Infect Dis, Baltimore, MD 21205 USA
[4] Ctr HIV & Hepatogastroenterol, Dusseldorf, Germany
[5] Hop La Pitie Salpetriere, Serv Med Interne, Paris, France
[6] Osped L Sacco, Div Malattie Infett, Milan, Italy
[7] Mt Sinai Med Ctr, Dept Med, New York, NY 10029 USA
[8] Univ Athens, Sch Med, Dept Hyg & Epidemiol, GR-11527 Athens, Greece
[9] Univ Bonn, Dept Med, D-5300 Bonn, Germany
关键词
D O I
10.1097/00002030-200401020-00001
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
[No abstract available]
引用
收藏
页码:1 / 12
页数:12
相关论文
共 116 条
[1]  
Aceti A, 2002, J ACQ IMMUN DEF SYND, V29, P41, DOI 10.1097/00042560-200201010-00005
[2]   Maintenance therapy with gradual reduction of the interferon dose over one year improves histological response in patients with chronic hepatitis C with biochemical response: results of a randomized trial [J].
Alric, L ;
Duffaut, M ;
Selves, J ;
Sandre, K ;
Mularczyck, M ;
Izopet, J ;
Desmorat, H ;
Bureau, C ;
Chaouche, N ;
Dalbergue, B ;
Vinel, JP .
JOURNAL OF HEPATOLOGY, 2001, 35 (02) :272-278
[3]   To biopsy or not to biopsy [J].
Andriulli, A ;
Mangia, A ;
Niro, G ;
Caturelli, E .
HEPATOLOGY, 2001, 34 (02) :438-439
[4]  
[Anonymous], 2002, Gastroenterology, V123, P2082, DOI 10.1053/gast.2002.1232082
[5]   Treatment of hepatitis C infection in injection drug users [J].
Backmund, M ;
Meyer, K ;
Von Zielonka, M ;
Eichenlaub, D .
HEPATOLOGY, 2001, 34 (01) :188-193
[6]   Severe liver mitochondriopathy with normal liver histology and normal lactate levels in patients receiving nucleoside analogues [J].
Batisse, D ;
Van Huyen, JPD ;
Piketty, C ;
Canali, GG ;
Karmochkine, M ;
Weiss, L ;
Bruneval, P ;
Kazatchkine, MD .
AIDS, 2002, 16 (17) :2370-2371
[7]   Low levels of hepatitis C virus RNA in serum, plasma, and peripheral blood mononuclear cells of injecting drug users during long antibody-undetectable periods before seroconversion [J].
Beld, M ;
Penning, M ;
van Putten, M ;
van den Hoek, A ;
Damen, M ;
Klein, MR ;
Goudsmit, J .
BLOOD, 1999, 94 (04) :1183-1191
[8]   Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients [J].
Benhamou, Y ;
Bochet, M ;
Di Martino, V ;
Charlotte, F ;
Azria, F ;
Coutellier, A ;
Vidaud, M ;
Bricaire, F ;
Opolon, P ;
Katlama, C ;
Poynard, T .
HEPATOLOGY, 1999, 30 (04) :1054-1058
[9]  
BERENGUER J, 2002, 42 INT C ANT AG CHEM
[10]  
Bonfanti P, 2001, J ACQ IMMUN DEF SYND, V27, P316